What is the market capitalization of Co-Diagnostics, Inc.?

Co-Diagnostics, Inc. (CODX) has a market capitalization of approximately 22,922,653 USD.

Where can I buy CODX in Canada?

CODX can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

CODX

Co-Diagnostics, Inc.

Co-Diagnostics, Inc. (CODX) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 23 million USD (micro-cap).

Details

Price6.22 USD

Market cap22.92 M USD

Payout ratio0.00%

ROE-151.66%

Debt / Equity12.66%

SectorHealthcare

Websiteco-dx.com

Updated yesterday

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.